Lv2
130 积分 2021-09-06 加入
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
3天前
已完结
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
3天前
已完结
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review
13天前
已完结
A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial
1个月前
已完结
Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
3个月前
已完结
Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma
1年前
已完结
Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis
1年前
已完结
The prognostic value of postoperative circulating cell-free DNA in operable hepatocellular carcinoma
1年前
已完结
Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma
1年前
已完结
The Evolving Management of Desmoid Fibromatosis
1年前
已完结
皖公网安备34019202002308
